Abstract
The COVID-19 pandemic has dramatically changed medical practice worldwide. It posed a significant impact on different health services, including dermatology. A Cross-sectional observational study of 200 healthcare providers and 100 dermatologists (survey 1 and 2, respectively) were conducted to determine the prevalence of occupational skin diseases among healthcare providers working amid the pandemic, and to demonstrate the outbreak’s impact on dermatology practice.
Most healthcare providers (83%) reported hygiene-related hand dermatitis. The rates of PPE- related dermatoses were estimated to be 73%, including pressure injuries (51.9%), acne (33.1%), non-gloves contact dermatitis (29.9%), nonspecific eruption (17.5%), urticaria (9.1%) and skin infections (3.2%). The emerging COVID-19-related cutaneous manifestations were recognized by 20% of surveyed dermatologists, including maculopapular eruption (41.67%), urticaria (37.50%), chilblain (25%) and vasculitis (16.67). Telemedicine was provided by 73% of the dermatologists, and 89% reported minimal use of immunosuppressive drugs amid the pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Non applicable
Funding Statement
Funding sources: None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Arab Board of Health Specialization, MOH Iraq
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Specialist dermatologist, MBChB, FABMS – Dermatology
↵^ Specialist dermatologist, MBChB, FIBMS – Dermatology
Conflicts of interest: None
Funding sources: None
Patient privacy and ethical use of images: The patients in this manuscript have given written informed consent for publication of their case details, including the use of images.
Data Availability
The used surveys are available for readers.
https://drive.google.com/drive/folders/1eH6inpIkkWpkJVmHYVNqmxXaBXQo9bJN?usp=sharing
